Our findings are in line with studies in melanoma, where Ptges deletion resulted in an increase in CD8+ T cell infiltration that synergized with αPD-1 therapy (55), and another model of breast cancer, where Ptges KD attenuated the extent of tumor-infiltrating monocytic MDSCs (mMDSCs) (40). The gene discussed is CD8A; the disease is breast carcinoma.